Natural killer cells also do not trigger the release of cytokines associated with CAR-T therapies. Our Joint Venture and Collaborations: The Immunotherapy Antibody Joint Venture: We entered into an agreement with NantBioCell, to establish a new joint venture called “The Immunotherapy Antibody JV. ...